Floatz logo

Bicarbonate Ion

Neoplasm

H. Lee Moffitt Cancer Center and Research InstituteSmall moleculePhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
89/ 100

Competitive context

890 Active assets in the Neoplasm cohort.

Asset / SponsorPhaseRating
Panitumumab
Astellas Pharma Inc
Phase 2BBB
Granulocyte Colony-Stimulating Factor Lenograstim
Sanofi
Phase 4BB
Dexmedetomidine
Medical College of Wisconsin
Phase 4BB
Lidocaine
Medical College of Wisconsin
Phase 4BB
Relatlimab
Bristol-Myers Squibb
Phase 2BB

View all 50 →

Same molecule, other indications

Bicarbonate Ion is also rated in:

obesity disorderActive
CC
Indicative · Phase 1
46 / 100
View asset →
prostate cancerActive
CC
Indicative · Phase 1/2
44 / 100
View asset →
metabolic acidosisDormant
CC
Indicative · Phase 1
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →